APOH and autoimmune polyendocrinopathy: Fickentscher et al. found significantly decreased serum sialylation levels in APS patients and asymptomatic carriers compared with those in a healthy population, which indicated that hyposialylated anti-β2GP1 IgG could be a new measure to distinguish healthy and asymptomatic populations 19.